Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.

Research output: Contribution to journal › Article › peer-review

Subject classification (UKÄ)

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{df9ce31c77cc4e87957c65de5936952b,

title = "Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.",

author = "Susanna Obad and Hans Brunnstr{\"o}m and Johan Vallon-Christersson and {\AA}ke Borg and Kristina Drott and Urban Gullberg",

year = "2004",

doi = "10.1038/sj.onc.1207524",

language = "English",

volume = "23",

pages = "4050--4059",

journal = "Oncogene",

issn = "1476-5594",

publisher = "Nature Publishing Group",

number = "23",

}

TY - JOUR

T1 - Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.

AU - Obad, Susanna

AU - Brunnström, Hans

AU - Vallon-Christersson, Johan

AU - Borg, Åke

AU - Drott, Kristina

AU - Gullberg, Urban

PY - 2004

Y1 - 2004

U2 - 10.1038/sj.onc.1207524

DO - 10.1038/sj.onc.1207524

M3 - Article

C2 - 15064739

SN - 1476-5594

VL - 23

SP - 4050

EP - 4059

JO - Oncogene

JF - Oncogene

IS - 23

ER -